Oncology Business Unit Leader

• Hold full P&L accountability for the Oncology Business Unit, including revenue delivery, expense management, and forecasting across the full oncology portfolio.
• Own the development and execution of the annual oncology business plan, aligning commercial strategy with Lilly Canada's affiliate-level objectives.
• Prepare, manage, and report on budgets and financial forecasts; monitor KPIs and take corrective action to achieve agreed financial targets.
• Drive revenue growth and brand uptake across promoted oncology products and pipeline launches, leveraging market insights to sharpen competitive positioning.
• Oversee all commercial operations across marketing, sales, and KOL engagement functions — ensuring seamless integration and accountability at every stage of the customer journey.

• Serve as a full member of the Lilly Canada Affiliate Leadership Team, contributing to enterprise-wide strategy, resource allocation, and affiliate culture.
• Represent the Oncology Business Unit's performance, challenges, and outlook at the affiliate level, providing regular updates to the VP & General Manager and the broader leadership team.
• Champion cross-functional integration and a culture of accountability across the affiliate, promoting shared goals and collective ownership of outcomes.
• Collaborate with other Business Unit Leads and functional heads (Medical, Regulatory, Finance, HR, Legal, Government Affairs) to advance affiliate-wide priorities.

• Provide strategic direction for all oncology brands in Canada — including identifying key customer insights, setting brand objectives, and developing integrated brand plans.
• Lead preparation and execution of short- and long-term brand strategies that are grounded in deep knowledge of the Canadian oncology landscape, competitive dynamics, and patient pathways.
• Act as player-coach for brand planning where needed, working directly alongside Brand Managers on material development and tactical execution.
• Foster a solution-focused contact strategy that enhances the customer experience while driving efficient resource deployment.
• Partner actively with global and regional brand teams to ensure Canada maximizes learnings from international markets and is positioned advantageously for global launches.

• Engage closely with the Market Access and Pricing & Reimbursement (PRA) teams to align commercial strategy with PMPRB guidelines, provincial formulary submission priorities, and pan-Canadian reimbursement processes (CDA/CADTH).
• Lead oncology-specific access strategy, including managing payer relationships, supporting Health Technology Assessment (HTA) submissions, and shaping reimbursement arguments at the provincial and national level.
• Partner with Government Affairs and Medical Affairs to inform and shape Health Canada regulatory and policy conversations relevant to the oncology portfolio.
• Support the development and delivery of value dossiers, pharmacoeconomic models, and reimbursement narratives in partnership with PRA colleagues.

• Lead, coach, and inspire the Oncology sales organization — via the Oncology National Sales Manager— to deliver high standards of customer engagement and business results.
• Build and maintain a high-performance sales culture rooted in accountability, continuous development, and exceptional customer service.
• Drive capability development across the sales team, with particular emphasis on institutional selling, account management, value-based selling, and oncology clinical acumen.
• Lead all national oncology sales meetings, POA cycles, and field coaching activities; model best-in-class selling behaviours.
• Manage field execution tracking and provide senior leadership with transparent reporting on key performance indicators and field activity.

• Serve as the commercial lead for oncology launch planning, ensuring Canada is positioned to maximize launch opportunities across multiple tumour types in the near-term pipeline.
• Work with Regulatory, Medical, and Global teams to understand upcoming product label developments and their commercial implications, integrating this intelligence into launch strategies early.
• Champion pre-launch stakeholder engagement with KOLs, Tumour Boards, provincial cancer agencies, and national oncology societies.
• Build and refine launch readiness frameworks to ensure the commercial team is trained, resourced, and strategically aligned well ahead of product approvals.

• Build and maintain relationships with key external stakeholders, including Key Opinion Leaders (KOLs), major academic cancer centres, provincial cancer agencies, and national oncology professional associations.
• Represent Lilly Canada in oncology at national scientific congresses, advisory boards, and relevant patient advocacy forums.
• Partner with Medical Affairs and Government Affairs to shape the external environment in support of the oncology portfolio.
• Leverage thought leader relationships strategically to inform brand strategy, strengthen Lilly's scientific reputation, and support access initiatives.

• Ensure that ethics and compliance are at the centre of all decisions and activities within the Oncology Business Unit; uphold Lilly's Code of Business Conduct at all times.
• Create and sustain a business unit culture that is winning, inclusive, customer-focused, and grounded in the Lilly values of Respect for People, Excellence, and Integrity.
• Foster an environment that promotes diversity, equity, and inclusion within the team and across partner functions.
• Hold team members accountable for adherence to all regulatory, legislative, and IMC Code of Ethical Practices standards.

• University degree required; graduate degree in business (MBA) or life sciences strongly preferred.

• Minimum 10 years of progressive pharmaceutical commercial experience, with at least 5 years in oncology.
• Demonstrated experience in senior commercial leadership, including direct management of multi-functional teams (marketing, sales, and/or access).
• Proven track record of delivering P&L results and managing full commercial accountability for a therapeutic business unit.
• Experience leading or contributing to oncology product launches in the Canadian market.
• Strong working knowledge of the Canadian oncology access and reimbursement environment, including HTA/CDA processes, provincial formulary submissions, and PMPRB regulations.
• Familiarity with Health Canada regulatory pathways and their commercial implications.

• Exceptional leadership presence and people management skills — ability to inspire, coach, and develop a high-performing multi-functional team.
• Strong strategic and analytical thinking, with the ability to translate complex data and market dynamics into clear, actionable plans.
• Deep customer and stakeholder focus — proven ability to build trust-based relationships with KOLs, payers, and cancer agency decision-makers.
• Outstanding communication and influencing skills across multiple organizational levels, including affiliate leadership and global/IBU partners.
• Demonstrated ability to lead through ambiguity and change, maintaining focus and team engagement during complex launch environments.
• High personal integrity and commitment to ethical conduct.

• Bilingual (English/French) strongly preferred, reflecting the bilingual nature of the Canadian market.
• Broad cross-functional experience (e.g., medical affairs, market access, business development) beyond core commercial roles.
• Experience managing or influencing IMC Code compliance and industry self-regulatory frameworks.
• Track record of building and launching oncology brands in competitive, rapidly evolving markets.

Eli Lilly